HeartSciences Inc. (HSCS) Total Liabilities (2021 - 2026)

HeartSciences (HSCS) has reported Total Liabilities for 6 consecutive years, with -$226060.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 105.63% year-over-year to -$226060.0; the trailing twelve-month figure through Apr 2026 stood at -$226060.0 (down 105.63% YoY), and the FY2026 full-year result was -$226060.0, down 105.63% from the prior year.
• Total Liabilities slipped to -$226060.0 in Q2 2026 per HSCS's latest filing, from $4.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $8.1 million in Q2 2022 and bottomed at -$226060.0 in Q2 2026.
• Historically, Total Liabilities has averaged $3.3 million across 5 years, with a median of $3.5 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Total Liabilities soared 83.81% in 2025, then plunged 105.63% in 2026.
• Over 5 years, Total Liabilities stood at $3.7 million in 2022, then gained by 8.95% to $4.0 million in 2023, then decreased by 6.41% to $3.8 million in 2024, then grew by 6.84% to $4.0 million in 2025, then slumped by 105.63% to -$226060.0 in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered -$226060.0, $4.0 million, and $1.8 million for Q2 2026, Q4 2025, and Q4 2025 respectively.